CLEC10A is a prognostic biomarker and correlated with clinical pathologic features and immune infiltrates in lung adenocarcinoma

CLEC10A, (C‐type lectin domain family 10, member A), as the member of C‐type lectin receptors (CLRs), plays a vital role in modulating innate immunity and adaptive immunity and has shown great potential as an immunotherapy target for cancers. However, there is no functional research of CLEC10A in pr...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Min, Han, Ying, Cai, Changjing, Liu, Ping, Chen, Yihong, Shen, Hong, Xu, Xingyuan, Zeng, Shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034442/
https://www.ncbi.nlm.nih.gov/pubmed/33655701
http://dx.doi.org/10.1111/jcmm.16416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034442/
https://www.ncbi.nlm.nih.gov/pubmed/33655701
http://dx.doi.org/10.1111/jcmm.16416

Ejemplares similares